Logo image of FGMC

FG MERGER II CORP (FGMC) Stock Fundamental Analysis

NASDAQ:FGMC - US30334J1025 - Common Stock

9.99 USD
+0.01 (+0.05%)
Last: 9/5/2025, 8:13:01 PM
9.95 USD
-0.04 (-0.4%)
After Hours: 9/5/2025, 8:13:01 PM
Fundamental Rating

2

Taking everything into account, FGMC scores 2 out of 10 in our fundamental rating. FGMC was compared to 0 industry peers in the Unkown industry. FGMC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. FGMC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year FGMC was profitable.
FGMC had a positive operating cash flow in the past year.
FGMC had negative earnings in each of the past 5 years.
In the past 5 years FGMC reported 4 times negative operating cash flow.
FGMC Yearly Net Income VS EBIT VS OCF VS FCFFGMC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -500K -1M

1.2 Ratios

Industry RankSector Rank
ROA 1.06%
ROE 1.07%
ROIC N/A
ROA(3y)-5.51%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FGMC Yearly ROA, ROE, ROICFGMC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 200 400 600 800

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for FGMC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FGMC Yearly Profit, Operating, Gross MarginsFGMC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024

More info and screens

6

2. Health

2.1 Basic Checks

FGMC has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for FGMC is higher compared to a year ago.
FGMC Yearly Shares OutstandingFGMC Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
FGMC Yearly Total Debt VS Total AssetsFGMC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

FGMC has an Altman-Z score of 206.83. This indicates that FGMC is financially healthy and has little risk of bankruptcy at the moment.
FGMC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 206.83
ROIC/WACCN/A
WACCN/A
FGMC Yearly LT Debt VS Equity VS FCFFGMC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

FGMC has a Current Ratio of 2.23. This indicates that FGMC is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 2.23 indicates that FGMC has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.23
Quick Ratio 2.23
FGMC Yearly Current Assets VS Current LiabilitesFGMC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 200K 400K 600K

More info and screens

0

3. Growth

3.1 Past

FGMC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1150.00%.
EPS 1Y (TTM)-1150%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28350%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

FGMC is valuated quite expensively with a Price/Earnings ratio of 124.88.
FGMC's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.06.
Industry RankSector Rank
PE 124.88
Fwd PE N/A
FGMC Price Earnings VS Forward Price EarningsFGMC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 103.05
EV/EBITDA N/A
FGMC Per share dataFGMC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

FGMC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FG MERGER II CORP

NASDAQ:FGMC (9/5/2025, 8:13:01 PM)

After market: 9.95 -0.04 (-0.4%)

9.99

+0.01 (+0.05%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)07-25 2025-07-25
Earnings (Next)N/A N/A
Inst Owners50.96%
Inst Owner Change26.32%
Ins Owners5.24%
Ins Owner Change0%
Market Cap102.90M
AnalystsN/A
Price TargetN/A
Short Float %0.92%
Short Ratio1.17
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 124.88
Fwd PE N/A
P/S N/A
P/FCF 103.05
P/OCF 103.05
P/B 1.25
P/tB 1.25
EV/EBITDA N/A
EPS(TTM)0.08
EY0.8%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.1
FCFY0.97%
OCF(TTM)0.1
OCFY0.97%
SpS0
BVpS7.96
TBVpS7.96
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.06%
ROE 1.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-5.51%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 114.28%
Current Ratio 2.23
Quick Ratio 2.23
Altman-Z 206.83
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1150%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28350%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1338.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y89.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y89.34%
OCF growth 3YN/A
OCF growth 5YN/A